Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice

Vinod Nair, Albina Arjuman, H. N. Gopalakrishna, M. Nandini

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The objective of the study was to evaluate the anticataleptic effect of Withania somnifera (WS) extract, on haloperidol-induced catalepsy in albino mice. Catalepsy was induced with haloperidol (1 mg/kg) i.p. in five groups of male albino mice (n = 6). Three groups received Withania somnifera extract (1.7, 4.25, 8.5 mg/kg) respectively, one group received scopolamine (1 mg/kg) and one group received the vehicle (1% gum acacia) orally, 30 min prior to haloperidol administration. Catalepsy was measured by using standard bar test at 30, 60, 90, 120 and 240 min. This constituted the acute study. For the chronic study, the drugs were administered for 6 more days. Catalepsy was again measured on day 7. Animals were then sacrificed by cervical dislocation and superoxide dismutase (SOD) activity was estimated in the brain. In this study, Withania somnifera extract treated groups showed a dose dependent reduction in cataleptic scores, both in the acute and chronic study. The SOD activity in brain was also found to be lowered in the WS (4.25 mg, 8.5 mg/kg) treated groups. In conclusion, Withania somnifera was found to be more efficacious than scopolamine in reversing haloperidol induced catalepsy. A clear correlation between the SOD levels and cataleptic scores was observed. We believe that the antioxidant properties of this drug could have contributed to the anticataleptic effect.

Original languageEnglish
Pages (from-to)243-246
Number of pages4
JournalPhytotherapy Research
Volume22
Issue number2
DOIs
Publication statusPublished - 01-02-2008

Fingerprint

Withania
Catalepsy
Haloperidol
Superoxide Dismutase
Scopolamine Hydrobromide
Gum Arabic
Brain
Pharmaceutical Preparations
Antioxidants

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Nair, Vinod ; Arjuman, Albina ; Gopalakrishna, H. N. ; Nandini, M. / Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice. In: Phytotherapy Research. 2008 ; Vol. 22, No. 2. pp. 243-246.
@article{635782c7f6d64602a5696ccb54a3599c,
title = "Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice",
abstract = "The objective of the study was to evaluate the anticataleptic effect of Withania somnifera (WS) extract, on haloperidol-induced catalepsy in albino mice. Catalepsy was induced with haloperidol (1 mg/kg) i.p. in five groups of male albino mice (n = 6). Three groups received Withania somnifera extract (1.7, 4.25, 8.5 mg/kg) respectively, one group received scopolamine (1 mg/kg) and one group received the vehicle (1{\%} gum acacia) orally, 30 min prior to haloperidol administration. Catalepsy was measured by using standard bar test at 30, 60, 90, 120 and 240 min. This constituted the acute study. For the chronic study, the drugs were administered for 6 more days. Catalepsy was again measured on day 7. Animals were then sacrificed by cervical dislocation and superoxide dismutase (SOD) activity was estimated in the brain. In this study, Withania somnifera extract treated groups showed a dose dependent reduction in cataleptic scores, both in the acute and chronic study. The SOD activity in brain was also found to be lowered in the WS (4.25 mg, 8.5 mg/kg) treated groups. In conclusion, Withania somnifera was found to be more efficacious than scopolamine in reversing haloperidol induced catalepsy. A clear correlation between the SOD levels and cataleptic scores was observed. We believe that the antioxidant properties of this drug could have contributed to the anticataleptic effect.",
author = "Vinod Nair and Albina Arjuman and Gopalakrishna, {H. N.} and M. Nandini",
year = "2008",
month = "2",
day = "1",
doi = "10.1002/ptr.2299",
language = "English",
volume = "22",
pages = "243--246",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice. / Nair, Vinod; Arjuman, Albina; Gopalakrishna, H. N.; Nandini, M.

In: Phytotherapy Research, Vol. 22, No. 2, 01.02.2008, p. 243-246.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice

AU - Nair, Vinod

AU - Arjuman, Albina

AU - Gopalakrishna, H. N.

AU - Nandini, M.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - The objective of the study was to evaluate the anticataleptic effect of Withania somnifera (WS) extract, on haloperidol-induced catalepsy in albino mice. Catalepsy was induced with haloperidol (1 mg/kg) i.p. in five groups of male albino mice (n = 6). Three groups received Withania somnifera extract (1.7, 4.25, 8.5 mg/kg) respectively, one group received scopolamine (1 mg/kg) and one group received the vehicle (1% gum acacia) orally, 30 min prior to haloperidol administration. Catalepsy was measured by using standard bar test at 30, 60, 90, 120 and 240 min. This constituted the acute study. For the chronic study, the drugs were administered for 6 more days. Catalepsy was again measured on day 7. Animals were then sacrificed by cervical dislocation and superoxide dismutase (SOD) activity was estimated in the brain. In this study, Withania somnifera extract treated groups showed a dose dependent reduction in cataleptic scores, both in the acute and chronic study. The SOD activity in brain was also found to be lowered in the WS (4.25 mg, 8.5 mg/kg) treated groups. In conclusion, Withania somnifera was found to be more efficacious than scopolamine in reversing haloperidol induced catalepsy. A clear correlation between the SOD levels and cataleptic scores was observed. We believe that the antioxidant properties of this drug could have contributed to the anticataleptic effect.

AB - The objective of the study was to evaluate the anticataleptic effect of Withania somnifera (WS) extract, on haloperidol-induced catalepsy in albino mice. Catalepsy was induced with haloperidol (1 mg/kg) i.p. in five groups of male albino mice (n = 6). Three groups received Withania somnifera extract (1.7, 4.25, 8.5 mg/kg) respectively, one group received scopolamine (1 mg/kg) and one group received the vehicle (1% gum acacia) orally, 30 min prior to haloperidol administration. Catalepsy was measured by using standard bar test at 30, 60, 90, 120 and 240 min. This constituted the acute study. For the chronic study, the drugs were administered for 6 more days. Catalepsy was again measured on day 7. Animals were then sacrificed by cervical dislocation and superoxide dismutase (SOD) activity was estimated in the brain. In this study, Withania somnifera extract treated groups showed a dose dependent reduction in cataleptic scores, both in the acute and chronic study. The SOD activity in brain was also found to be lowered in the WS (4.25 mg, 8.5 mg/kg) treated groups. In conclusion, Withania somnifera was found to be more efficacious than scopolamine in reversing haloperidol induced catalepsy. A clear correlation between the SOD levels and cataleptic scores was observed. We believe that the antioxidant properties of this drug could have contributed to the anticataleptic effect.

UR - http://www.scopus.com/inward/record.url?scp=40549128721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549128721&partnerID=8YFLogxK

U2 - 10.1002/ptr.2299

DO - 10.1002/ptr.2299

M3 - Article

C2 - 17886228

AN - SCOPUS:40549128721

VL - 22

SP - 243

EP - 246

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 2

ER -